Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
130 Cards in this Set
- Front
- Back
- 3rd side (hint)
What Topo class are the camptothecin analogs?
|
Topoisomerase I inhibitors
|
RM: the drugs are topotecan and irinotecan
RM: Topo I causes single stranded DNA breaks |
|
Topotecan and Irinotecan are in what drug class?
|
Camptothecin analong --> Topo I inhibitors
|
|
|
What are the 2 Topo II inhibitors? (subclasses)
|
anthracycline analogs
Epipodophyyotoxins |
|
|
The 2 epipodophyllotoxins are...
|
Etoposide
Teneposide |
|
|
Doxorubicin, daunorubicin, idarubicin, epirubicin, & mitoxantrone are in what subclass and class?
|
subclass: anthracycline analogs
|
class: Topo II inhibitors
|
|
Camptothecin analogs are ___ phase-specific drugs.
|
S
What do they inhibit? |
The religation of single-stranded breaks in DNA
|
|
Brand and Cancer type for Topotecan?
|
Hycamtin
(Camptothecin Analogs) |
solid
|
|
Topotecan undergoes hydrolysis and then the _____ opens up?
|
lactone ring
|
RM dose reduction for renal impairment & short half life
|
|
Irinotcan Class?
|
Camptothecin Analogs
(Topo I inhibitor) |
|
|
Irinotecan is metabolized by hepatic carboxylesterase to _____ which is the active form.
|
SN-38
Why is this less hydrolyzed? |
bc high plasma protein binding
|
|
Serious SE of Irinotecan?
|
diarrhea
why? |
bc high level of SN-38 in GI from beta glucorionodase reactivating it
|
|
Anthracyclines are good for ___ tumors.
|
solid
|
|
|
Big SE of Anthracyclines?
|
Cardiotoxicity
why? |
bc produces toxins for H2O2 and in heart there's low dexrazoxane (and Fe chelator) and so can't prevent hydroxy radical formation
|
|
How are anthracyclines eliminated?
|
liver
(so dose adjustment needed if impaired) |
|
|
Class of Doxorubicin?
|
anthracyclines
(topo II inhibitors) |
|
|
Avoid ____ in combo with Doxorubicin?
|
cyclophosphamide
(also anthracyclines and herceptin) |
can further cardiotoxicity
|
|
This anthracycline causes infusion rxns and hand-foot syndrome...
|
Doxorubicin Liposoaml
(BRAND: DOXIL) |
|
|
Brand and class for Daunorubicin?
|
Cerubidine
|
anthracycline
(Topo II inhibitor) |
|
Daunorubicin is eliminated by....
|
kidneys
(result...) |
red-urine
|
|
This anthracycline is metabolized by hepatic and renal systems...
|
Epirubicin (Ellence)
|
|
|
Brand and cancer type for Epirubicin?
|
Ellence
(anthracyclines) |
solid
|
|
Brand and cancer type for Idarubicin?
|
Idamycin
(anthracyclines) |
AML
ALL |
|
____ has less cardiotoxicity than the other anthracyclines
|
Mitoxantrone
(Novantrone) |
|
|
Brand and Class for Mitoxantrone?
|
Novantrone
|
(anthracycline)
|
|
Epipodophyllotoxins are most sensitive in cells during the _____ and G2 phase.
|
S
|
|
|
Brand and Class for Etoposide?
|
Vp-16
Vepesid |
Epipodophyllotxins
(lymphoma and solid) |
|
Vincristine, vinblastine, vindesine, and vinorelbine are all _____
|
vinca alkaloids
|
antimitotic agents
|
|
Antimitotic agents target _____
|
microtubule
|
|
|
Name the 3 taxanes (antimitotics)
|
paclitaxel
docetaxel cabazitaxel |
|
|
Ixabepilone subclass? And class?
|
epothilones
|
antimitotic
|
|
Eribulin subclass? and class?
|
Halichondrin B analog
|
antimitotic
|
|
All antimitotic agents are ____ phase-specific cytotoxins
|
M
|
|
|
Vinca alkaloids bind to _____ and blocks its abilty to polymerize with ____
|
B-tubulin
|
alpha-tubulin
RM hepatic metabolism |
|
Brand and cancer type for Vincristine...
|
Oncovin
Vincasar |
ALL
lymphoma solid |
|
Vincristine is in a _____ formulation
|
liposomal
|
RM: big t1/2 range bc hepatic
|
|
Brand and cancer type for Vinblastine...
|
Velban
|
lymphoma
solid |
|
Brand and cancer type for Vindesine?
|
Eldisine
|
ALL
CML lymphoma solid |
|
Do vinca alkaloids cause vesicant?
|
yes
|
|
|
Class for Vinorelbine?
|
vinca alkaloid
(solid cancer type) |
|
|
Taxanes promote the _____ of microtubules and is ___ phase-specific
|
polymerization
|
M
|
|
Taxanes have extensive _____ metabolism
|
hepatic
|
|
|
Brand and class for Paclitaxel?
|
Taxol
|
taxane (antimitotic)
|
|
You add 50% ethanol with this to prevent toxicity
|
cremophor EL
|
|
|
Which taxane is dose-dependent? How is it's severe myleosuppression alleviated?
|
Paclitaxel (Taxol)
|
by filgrastim
|
|
Abraxane generic?
|
Paclitaxel protein-bound
(albumin) |
solid cancer type
|
|
Docetaxel has ____ PK.
|
linear
|
|
|
Does Taxotere cause fluid retention?
|
yes --> leads to peripheral edema
|
|
|
Brand for Cabazitaxel and class?
|
Jevtanan
|
taxane
|
|
Class for Ixabepilone?
|
epothilones (antimitotic)
|
|
|
Brand for Eribulin?
|
Halaven
|
|
|
Brand for Estramustine?
|
Emcyt
|
|
|
Estramustine is made up of ____ and ____
|
estradiol and normustin
|
RM good bc little myelosuppression but get impotence and edema
|
|
Etoposide has a ___ in it's R group. Teniposide has a ____ in it's R group.
|
CH3
C=C-S-C=C-C (penta ring) |
these are epipodophyllotoxins (topo II)
|
|
Which taxane is more water soluble and is more potent?
|
Docetaxel
|
|
|
The 2 differentiating agents?
|
All-Trans Retinoic Acid (ATRA)
Arsenic Trioxide (ATO) |
|
|
This drug promotes the degradation of PML-RAR-alpha fusion protein...
|
ATRA
|
|
|
2 unique toxicities for differentiating agents?
|
leukocytosis
APL differentiation syndrome |
RM ATO can cause QT prolongation bc of metal in formulation
|
|
Tamoxifen, toremifene and raloxifene are what type of Anti-Estrogen therapies?
|
SERMS
selective estrogen-receptor modulators |
|
|
Aromatase inhibitors? (3)
|
exemestane, anastrozole, and letrozole
what good for? |
breast cancer
RM all 3 of these agents cause dec in bone mineral density |
|
Fulvestrant is a ____. Goserelin is a _____.
|
SERD
selective estrogen-receptor down-regulator |
LHRH
Lutinizing hormone-releasing hormone agonists |
|
Tamoxifen is ____ in breast cells and ___ in the uterus' endometric cells
|
anti-estrogenic
|
estrogenic
|
|
Fulvestrant is given ____.
|
IM
It _____ ER dimerization and ____ its degradation. |
inhibit
increase |
|
Goserelin is given ____.
|
SQ
is it ok for men? |
yes
breast and prostate |
|
Goserelin is given ____.
|
SQ
is it ok for men? |
yes
breast and prostate (but tmax and t1/2 differ) |
|
Aromatase is resp for converting _____ to ____
|
testosterone
|
estrone (estradiol)
|
|
Exemestane is a Type ___ AI because it has a ____ in it.
|
1
|
steroid
|
|
Degarelix is a ____ anatagonist.
|
LHRH
|
|
|
Leuprolide and Triptorelin drug class and use?
|
LHRH agonist
|
prostate cancer
(along with goserelin which is used for breast cancer also) |
|
Flutamide, Bicalutamide, and Nilutamide are ______
|
androgen receptor blockers
|
|
|
Leuprolide is given ___ and ____. Triptoerlin is given ___.
|
IM and SQ
|
IM only
RM Trip can get hypersensitivity bc it is a peptide itself |
|
Degarelix is given ____
|
SQ
|
RM competes with LHRH
|
|
The androgen receptors can cause _____ bc extensive ____ metabolism.
|
hepatotoxicity
|
liver
|
|
Bortezomib is given ___ or ____
|
IV or SQ
What does it inactivate? |
NFKA
(by being a 26S proteasome inhibitor) |
|
Big toxicity of thalidomide?
|
birth defects
|
used for multiple myelomas
|
|
L-asparaginase inhibits _____ and causes cell death.
|
protein synthesis
How is it given? |
IV or IM
|
|
Due to it's protein synthesis inhibition this drug causes hyperglycemia, clotting abnormalities, and hyperTG's leading to pancreatitis...
|
L-Asparaginase
|
|
|
Bleomycin max dose is ___
|
400 units per lifetime
How given? |
Given IM, IV, and SQ
|
|
What is gene mutation is responsible for acute promyelocytic leukemia (APL)?
|
PML-RAR-alpha
|
RM: APL is a subtype of AML
|
|
To treat APL, ATRA is given ____ and arsenic trioxide is given _____
|
PO
|
IV
|
|
Which anti-cancer drug depends on whether or not the cancer cell is ER-positive?
|
Anti-Estrogen therapy
|
*breast cancer cells
|
|
Is Tamoxifen useful in postmenopausal cancer?
|
no
|
|
|
What 2 toxicities does Raloxifene have increased vs Tamoxifen?
|
inc stroke w/ coronary heart disease
inc thromboembolic disease |
|
|
This drug is known as the "pure ant-estrogen"
|
Fulvestrant
|
RM good for tamoxifen resistant cells
|
|
Megestrol is a synthetic ____
|
progesterone
|
RM: will act on neg FB can dec estrogen levels
|
|
What will help Exemestane's absorption?
|
if taken after a high fat meal
|
|
|
This drug has an increased risk for CV disease due to androgen deprivation.
|
Bicalutamide
|
Anti-androgen med
Blocks the androgen receptor |
|
These two drugs have 4 possible MOA's including: G1 arrest, apoptosis
inhibits cell adhesion decreases angiogenesis increases NK cell activity |
Thalidomide
Lenalidomide |
RM: both given by mouth
|
|
With this drug can get high distribution in skin and lungs, plus can cause pulmonary fibrosis.
|
Bleomycin
|
RM also can cause cutaneous rxns (hyperpigmentation, erythema, and ulceration)
|
|
MOA for Bleomycin?
|
causes single and double stranded breaks
Cancer types? |
lymphoma
melanoma testicular |
|
4 subclasses of kinase inhibitors?
|
ABL inhibitors
EGFR inhibitors B-Raf inhibitor ALK inhibitor |
|
|
Imatinib, dasatinib, and nilotinib???
|
ABL inhibitors
|
|
|
Gefitinib, erlotinib, and lapatinib class?
|
EGFR inhibitors
|
Kinase inhibitors
|
|
MOA of ABL inhibitors?
|
inhibit kinase activity by binding to the pocket of ABL and thus competes with ATP needed for phosphylation
|
|
|
Most potent ABL Kinase Inhibitor?
|
Nilotinib
|
|
|
Which ABL inhibitor causes cardiotoxicity?
|
Nilotinib
|
|
|
ErbB2 is overexpressed in ____ cancer
|
breast
|
|
|
MOA of EGFR inhibitors?
|
inhibits EGFR tyrosine kinase
|
|
|
What is the special toxicity of EGFR inhibition?
|
rash development
|
|
|
This is a dual tyrosine kinase inhibitor
|
Lapatinib
inhibits EGFR and HER2 |
|
|
This is a dual tyrosine kinase inhibitor
|
Lapatinib
inhibits EGFR and HER2 |
RM causes cardio and pulmonary toxicity
|
|
This drug inhibits proliferation of melanoma cells with B-RAF(V600E), and causes apoptosis.
|
Vemurafenib
Toxicities? |
cutaneous squamous cell carc
|
|
Kinases inhibitors are given ____
|
by mouth
|
|
|
This drug blocks ALK?
|
Crizotinib
Toxicities (3 main) |
vision impairment
GI cardio |
|
Rituximab is anti-____
|
CD20
|
induces apoptosis in tumor cells via ADCC and CDC
|
|
Ofatumumab is anti-____
|
CD20
(but not identical to Rituximab) |
|
|
Alemtuzumab is anti-____
|
CD52
|
induces apoptosis in tumor cells via ADCC and CDC
|
|
Brentuximab vedotin is anti-____
|
CD30
|
RM: it's an antibody-drug conjugate (made of 3 components --> CD30, MMAE, and protease-cleavable linker)
|
|
Cetuximab is anti-____
|
EGFR (ErbB1, HER1) --> very good for colon cancer therapy
|
induces apoptosis in tumor cells via ADCC
RM can cause rash/dry skin & cardiopulmonary arrest |
|
Panitumumab is anti-____
|
EGFR (ErbB1, HER1)
|
does NOT induce ADCC (unlike cetuximab)
|
|
Trastuzmab is anti-____
|
HER2/neu (ErbB1)
|
induces apoptosis in tumor cells via ADCC & blocks angiogenesis
|
|
Bevacizumab is anti-____
|
VEGF (needed for tumor BV development)
most serious toxicity (4)? |
hemorrhaging
GI perforation thromboemolism poor wound healing |
|
Which part of Brentuximab Vedotin causes disruption of micro-tubules (apoptosis) and cytotoxicity as well?
|
MMAE
(free = cytotoxicity) |
RM get peripheral neuropathy bc of microtubule distruption of MMAE
|
|
To prevent cardiotoxicity of Trastuzumab, which 2 drugs should it not be combined with?
|
Doxorubicin
Cyclophosphamide |
|
|
5 alkylating agents that treat solid tumors?
|
cyclophosphamide
cisplatin carboplatin ifosfamide oxalitplatin |
|
|
Alkylating agents that are PO?
|
cyclophosphamide
chlorambucil busulfan procarbazine |
rest are by IV
|
|
Antimetaboites are all ___ phase specific.
|
S
|
bc they block DNA synthesis
|
|
5-FU and prodrug capecitabine MOA?
|
inhibit thymidylate synthase
|
antimetaboites
RM: capecitabine bc 5-FU in body |
|
MOA of pyrimidine analogs?
|
block DNA synthesis by getting incorp in DNA
|
|
|
What 5 antimetabolites work on solid tumors?
|
MTX
Pemetrexed 5-FU Capecitabine Gemcitabine |
|
|
What 4 antimetabolites are given PO?
|
Capecitabine
6-Mercaptopurine Fludarabine Hydroxyurea |
rest are IV infusion
|
|
Which 2 antimetabolites cause Hand-Foot syndrome?
|
5-FU
capecitabine |
also seen in Doxurubcin lip formulation
|
|
Which two topo inhibitors treat luekemia/lymphoma?
|
daunorubicin
idarubicin |
rest treat solid
|
|
All Topo Inhibitors are give ____
|
IV
|
|
|
Taxanes and Ixabepilone ___ microtubule polymerization?
|
promote
|
RM these two get hypersensitivity rxn bc of solvents
|
|
Which 3 antimitoic agents can be used for solid and leukemia?
|
vincristine
vinblastine Vindesine |
all others = solid
|
|
Vincristine and estramustine both have very limited _____
|
myelosuppression
|
all other antimitotics cause more
|
|
BCR-ABL inhibitors are used for ____
|
CML
|
RM imatinib is least potent and maybe resistant for CML
and this subclass only ones that cause myelosuppression |
|
All kinase inhibitors undergo extensive _____ metabolism
|
hepatic
|
|
|
All MAb are given ____ and are dose-_____.
|
IV
(RM infusion rxn bc large amounts of protein) |
dependent
|
|
Which 3 drug target of MAb cause myleosuppression?
|
CD20
CD30 CD52 |
all others do not cause
|